Epizyme, Inc.
Method for treating cancer
Last updated:
Abstract:
The present disclosure relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
Status:
Grant
Type:
Utility
Filling date:
22 Oct 2019
Issue date:
26 Jan 2021